208 related articles for article (PubMed ID: 20590576)
1. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex.
Ho WS; Patel S; Thompson JR; Roberts CJ; Stuhr KL; Hillard CJ
Br J Pharmacol; 2010 Jun; 160(3):736-46. PubMed ID: 20590576
[TBL] [Abstract][Full Text] [Related]
2. The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat.
Patel S; Gerrits R; Muthian S; Greene AS; Hillard CJ
Neurosci Lett; 2002 Dec; 335(2):95-8. PubMed ID: 12459507
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Hampson RE; Miller F; Palchik G; Deadwyler SA
Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
[TBL] [Abstract][Full Text] [Related]
4. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
Pfitzer T; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
[TBL] [Abstract][Full Text] [Related]
5. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
6. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
8. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.
Mendiguren A; Pineda J
Br J Pharmacol; 2009 Nov; 158(6):1579-87. PubMed ID: 19845674
[TBL] [Abstract][Full Text] [Related]
9. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
10. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus.
Jergas B; Schulte K; Bindila L; Lutz B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):621-8. PubMed ID: 24853577
[TBL] [Abstract][Full Text] [Related]
11. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory.
Atsak P; Hauer D; Campolongo P; Schelling G; McGaugh JL; Roozendaal B
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3504-9. PubMed ID: 22331883
[TBL] [Abstract][Full Text] [Related]
13. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.
Hillard CJ; Ho WS; Thompson J; Gauthier KM; Wheelock CE; Huang H; Hammock BD
Br J Pharmacol; 2007 Nov; 152(5):691-8. PubMed ID: 17891162
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.
Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Tóth ZE; Balla A; Catt KJ; Hunyady L
J Biol Chem; 2012 Sep; 287(37):31540-50. PubMed ID: 22787147
[TBL] [Abstract][Full Text] [Related]
16. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2.
Jelsing J; Galzin AM; Guillot E; Pruniaux MP; Larsen PJ; Vrang N
Brain Res Bull; 2009 Mar; 78(4-5):202-10. PubMed ID: 19038314
[TBL] [Abstract][Full Text] [Related]
17. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
18. Protective activation of the endocannabinoid system during ischemia in dopamine neurons.
Melis M; Pillolla G; Bisogno T; Minassi A; Petrosino S; Perra S; Muntoni AL; Lutz B; Gessa GL; Marsicano G; Di Marzo V; Pistis M
Neurobiol Dis; 2006 Oct; 24(1):15-27. PubMed ID: 16762556
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
20. CB(1) cannabinoid receptor activation dose dependently modulates neuronal activity within caudal but not rostral song control regions of adult zebra finch telencephalon.
Soderstrom K; Tian Q
Psychopharmacology (Berl); 2008 Aug; 199(2):265-73. PubMed ID: 18509622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
